Detalhe da pesquisa
1.
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Clin Gastroenterol Hepatol
; 22(3): 581-590.e6, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871842
2.
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
J Formos Med Assoc
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423922
3.
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
Hepatol Res
; 53(10): 1021-1030, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291079
4.
Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.
J Formos Med Assoc
; 122(8): 747-756, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868900
5.
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection.
J Formos Med Assoc
; 122(10): 1008-1017, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147239
6.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333150
7.
Paradigm shift in the treatment options of hepatocellular carcinoma.
Liver Int
; 42(9): 2067-2079, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515412
8.
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
J Formos Med Assoc
; 120(3): 956-964, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077341
9.
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
J Formos Med Assoc
; 119(1 Pt 1): 3-11, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31627984
10.
Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients.
J Formos Med Assoc
; 119(3): 712-719, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31672433
11.
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions.
J Infect Dis
; 220(4): 557-566, 2019 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957170
12.
Letter to the Editor: Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
Hepatology
; 78(5): E97, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738208
13.
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C.
J Formos Med Assoc
; 118(8): 1187-1192, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279502
14.
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.
J Formos Med Assoc
; 118(2): 556-564, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30527566
15.
Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.
J Med Ultrasound
; 27(2): 81-85, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316217
16.
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy.
J Formos Med Assoc
; 121(2): 451-453, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454796
17.
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Liver Int
; 36(12): 1755-1764, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634134
18.
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Lancet
; 381(9862): 205-13, 2013 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23158886
19.
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.
Proc Natl Acad Sci U S A
; 108(9): 3719-24, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321200
20.
A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin.
J Formos Med Assoc
; 113(10): 716-21, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974131